Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
PSA (show PLAG1 Antibodies) velocity can be more predictive after surgery and PSA (show PLAG1 Antibodies) doubling time can be more predictive after radiation therapy.
Salvage radiotherapy conferred better prostate cancer control when administered at the very first sign of PSA (show PLAG1 Antibodies) rise.
Dynamic changes of ALP (show ALP Antibodies), LDH and PSA (show PLAG1 Antibodies) during Abiraterone-therapy are associated with best clinical benefit and OS in bone metastatic castration resistant prostate cancer
Studies indicate that the prostate health index (phi) is a biomarker panel that includes free prostate-specific antigen (PSA), total PSA (show PLAG1 Antibodies), and [-2]proPSA.
PSCA (show PSCA Antibodies) TT genotype is associated with a more than a threefold increase in the prevalence and the extent of gastric mucosal intestinal mucosa compared to C allele carriers among H. pylori-infected Bhutanese.
Prostate magnetic resonance imaging before prostate biopsy appeared to offer similar diagnostic accuracy compared with routine transrectal ultrasound-guided random biopsy in the diagnosis of suspected prostate cancer based on elevated prostate specific antigen values.
We observed an association of higher Ki-67 (show MKI67 Antibodies) expression with Gleason sum National Comprehensive Cancer Network risk (P=0.013) and PSA (show PLAG1 Antibodies) recurrence
Results show that urinary PSA (show PLAG1 Antibodies) glycoforms are able to discriminate prostate cancer from protastatic hyperplasia with higher sensitivity and specificity for prostate cancer than those of the serum PSA (show PLAG1 Antibodies) marker.
results suggest that overexpression of CRISP-3 (show CRISP3 Antibodies) in prostate tumor may maintain higher PSA (show PLAG1 Antibodies) expression and lower ANXA1 (show ANXA1 Antibodies) expression
No significant differences in in KLK3 (show KLKB1 Antibodies) expression were found between radical prostatectomy-prostate cancer and radical prostatectomy-benign samples.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Its protein product is a protease present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. Serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms.
, prostate specific antigen
, prostate-specific antigen
, plasma kallikrein B1
, kallikrein-related peptidase 3